Editorial: Heterogeneity in breast cancer: clinical and therapeutic implications
- PMID: 38469228
- PMCID: PMC10926019
- DOI: 10.3389/fonc.2024.1321654
Editorial: Heterogeneity in breast cancer: clinical and therapeutic implications
Keywords: breast cancer; drug resistance; emerging technologies; heterogeneity; molecular mechanisms.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Heterogeneity in breast cancer: clinical and therapeutic implications
Similar articles
-
The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity.Front Oncol. 2023 May 17;13:1170264. doi: 10.3389/fonc.2023.1170264. eCollection 2023. Front Oncol. 2023. PMID: 37265795 Free PMC article. Review.
-
Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancer.J Pathol. 2023 Aug;260(5):621-636. doi: 10.1002/path.6158. Epub 2023 Aug 16. J Pathol. 2023. PMID: 37587096 Review.
-
Editorial: Preclinical models and emerging technologies to study the effects of the tumor microenvironment on cancer heterogeneity and drug resistance.Front Oncol. 2023 Sep 28;13:1289756. doi: 10.3389/fonc.2023.1289756. eCollection 2023. Front Oncol. 2023. PMID: 37841424 Free PMC article. No abstract available.
-
A mathematical model for phenotypic heterogeneity in breast cancer with implications for therapeutic strategies.J R Soc Interface. 2022 Jan;19(186):20210803. doi: 10.1098/rsif.2021.0803. Epub 2022 Jan 26. J R Soc Interface. 2022. PMID: 35078336 Free PMC article.
-
Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications.Semin Cancer Biol. 2022 Nov;86(Pt 2):769-783. doi: 10.1016/j.semcancer.2022.03.008. Epub 2022 Mar 9. Semin Cancer Biol. 2022. PMID: 35278636 Review.
Cited by
-
Prognostic Relevance of Inflammatory Cytokines Il-6 and TNF-Alpha in Patients with Breast Cancer: A Systematic Review and Meta-Analysis.Curr Oncol. 2025 Jun 11;32(6):344. doi: 10.3390/curroncol32060344. Curr Oncol. 2025. PMID: 40558287 Free PMC article. Review.
-
Investigating Vitamin D3's anticancer mechanisms in MCF-7 cells: a network pharmacology and omics technology approach.Mol Divers. 2025 Mar 27. doi: 10.1007/s11030-025-11156-z. Online ahead of print. Mol Divers. 2025. PMID: 40146431
-
Association between neutrophil-lymphocyte ratio and female breast cancer: an observational study from NHANES 2001-2018 with external validation.Front Oncol. 2025 Jul 8;15:1564238. doi: 10.3389/fonc.2025.1564238. eCollection 2025. Front Oncol. 2025. PMID: 40697377 Free PMC article.
-
Prognostic Significance of E2F8, LIN28b, MACC1, and CCT3 Genes in Breast Cancer: Implications for Survival and Therapeutic Stratification.Iran J Biotechnol. 2025 Apr 1;23(2):e4051. doi: 10.30498/ijb.2025.497569.4051. eCollection 2025 Apr. Iran J Biotechnol. 2025. PMID: 40860052 Free PMC article.
-
Breast cancer histopathology, classification and clinical management: Current perspectives.Bioinformation. 2024 Dec 31;20(12):2069-2079. doi: 10.6026/9732063002002069. eCollection 2024. Bioinformation. 2024. PMID: 40230896 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources